600976.SH
健民集团
SSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
CNY 27.58
+0.15%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
9.3x
Market Cap
CNY 4.23B
MomentumView details →
1D Return
+0.15%
YTD Return
−16.44%
RSI (14)
47.7
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
9.3x
Market Cap
CNY 4.23B
RSI (14)
47.7
MomentumView details →
1D Return
+0.15%
YTD Return
−16.44%
Similar companies
Latest newsMore news →
Jianmin Group announced that its Crisaborole Ointment received approval from China's National Medical Products Administration and was launched on the market.2d agoJianmin Group announced its 2026 half-year results: revenue of 1.611 billion yuan, down 10.72% year-on-year; net profit attributable to shareholders of 177 million yuan, down 19.68% year-on-year.17d ago